Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Zynerba Pharma CS (ZYNE)

Zynerba Pharma CS (ZYNE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3000 +0.0300 (+2.36%) 10/10/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3000 unch (unch) -
News & Headlines for Tue, Oct 10th, 2023
Why Shares of Harmony Bioscience Are Falling on Friday

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

HRMY : 29.61 (+0.61%)
ZYNE : 1.3000 (+2.36%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CPRI, CEQP, CELL, ZYNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CPRI : 14.87 (+1.16%)
ZYNE : 1.3000 (+2.36%)
CELL : 0.9981 (+0.31%)
CEQP : 28.26 (+4.36%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, ZYNE, HEP, CEQP

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HEP : 20.45 (-0.78%)
ZYNE : 1.3000 (+2.36%)
AVID : 27.04 (unch)
CEQP : 28.26 (+4.36%)
Shareholder Alert: Ademi LLP investigates whether Zynerba Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Harmony

/PRNewswire/ -- Ademi LLP is investigating Zynerba (Nasdaq: ZYNE) for possible breaches of fiduciary duty and other violations of law in its transaction with...

ZYNE : 1.3000 (+2.36%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CPRI, AVID, ZYNE, HEP

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HEP : 20.45 (-0.78%)
CPRI : 14.87 (+1.16%)
ZYNE : 1.3000 (+2.36%)
AVID : 27.04 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, DBTX, VRTV, ZYNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
ZYNE : 1.3000 (+2.36%)
DBTX : 4.91 (-0.81%)
TRHC : 10.50 (+0.86%)
Zynerba: Q2 Earnings Snapshot

Zynerba: Q2 Earnings Snapshot

ZYNE : 1.3000 (+2.36%)
HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...

HRMY : 29.61 (+0.61%)
ZYNE : 1.3000 (+2.36%)
Zynerba: Q1 Earnings Snapshot

Zynerba: Q1 Earnings Snapshot

ZYNE : 1.3000 (+2.36%)
Zynerba: Q4 Earnings Snapshot

Zynerba: Q4 Earnings Snapshot

ZYNE : 1.3000 (+2.36%)

Barchart Exclusives

Amazon’s Secretive ‘Project Greenland’ Was an AI Success. Should You Buy AMZN Stock Now?
Amazon has quietly solved the GPU shortage plaguing Big Tech through a bold internal initiative, positioning it to lead the next phase of AI and cloud innovation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective